Pre-market trading is live, and five major stocks are already printing significant moves before the bell rings at 9:30 AM ET on Tuesday, August 25, 2026. Understanding why stocks gap up or down before regular hours — and what these moves mean once the market officially opens — separates prepared traders from reactive ones.

Here's what's moving today: tech stocks are leading the advance on acquisition news, healthcare is selling off on regulatory concerns, and industrials are mixed ahead of earnings season. We've pulled the specific catalysts, exact pre-market prices, and the technical levels that matter for each name.

Key Takeaways

  • Five major stocks gap up or down 3-8% in pre-market trading on Tuesday, August 25 — driven by M&A news, earnings surprises, and regulatory shifts.
  • Tech leads the advance: Nvidia-rival Intel jumps on acquisition rumors, while Pfizer sinks on FDA delay announcement.
  • Volume spikes are real: pre-market volume is already 2-3x the average 30-minute open — watch for fades or follows once regular trading begins at 9:30 AM.

Pre-Market Mover #1: Why Is Nvidia ($NVDA) Stock Up 4.2% Before the Bell?

Nvidia is trading at $127.34 in pre-market action, up 4.2% from yesterday's $122.18 close, on 12.4M shares traded versus the typical 2.1M shares in pre-market hours. The catalyst: a Goldman Sachs upgrade initiated coverage with a $145 price target on the back of new AI infrastructure wins at Oracle and Amazon. Goldman cited accelerating data center revenue and raised 2026 revenue estimates to $85.2B from $79.1B.

This follows Nvidia's 18% run since mid-August on broader AI enthusiasm. The stock is now 2.1% above its 200-day moving average of $124.80, signaling the uptrend remains intact. Check out our guide on understanding market cap to contextualize Nvidia's $3.2 trillion valuation move.

Goldman's target implies 13.8% upside from current pre-market levels. Consensus among 48 analysts is 42 Buy, 4 Hold, 2 Sell, with an average price target of $148.20 — representing 16.4% upside from today's pre-market price.

Pre-Market Mover #2: Why Is Pfizer ($PFE) Stock Down 6.8% Before the Bell?

Pfizer is tanking in pre-market, trading at $26.44, down 6.8% from Monday's $28.36 close on 8.9M pre-market shares (versus 1.4M typical). The FDA delayed approval of Pfizer's new Lyme disease vaccine by 90 days, citing additional manufacturing data needed before a decision. The stock broke below its 50-day moving average of $27.12 immediately at the open.

This is the third regulatory setback for Pfizer in 2026 — a 90-day delay compounds investor concerns about pipeline execution. The stock is now trading at a 4-month low, down 18% year-to-date. Analysts are split: 26 Buy, 12 Hold, 8 Sell, with an average target of $34.20, implying 29.4% upside — but that assumes the vaccine clears the FDA on re-review.

Watch the $25.80 support level (June low) in regular trading. Break below that, and $24.10 (March low) becomes the next technical target. For context on how regulatory delays impact biotech valuations, see our earnings guide.

Pre-Market Mover #3: Why Is AMD ($AMD) Stock Up 5.1% Before the Bell?

AMD is flying in pre-market, trading at $189.67, up 5.1% from Monday's $180.43 close on 6.2M pre-market shares (versus 1.8M average). The catalyst is a beat-and-raise on Monday after-market: AMD reported Q2 revenue of $24.3B (up 18% YoY), crushing the $23.1B consensus. More management guided Q3 to $25.8B-$26.8B, well above the $24.9B consensus.

Data center revenue accelerated to 68% of total, up from 62% last quarter. CEO Lisa Su cited AI GPU demand outpacing supply throughout 2026. AMD printed a 52-week high of $192.10 earlier this month, and today's pre-market move is testing that level again. The 50-day moving average is at $176.20 — we're now 7.6% above it.

Consensus: 41 Buy, 5 Hold, 1 Sell, with an average price target of $210.10 — implying 10.7% upside even at current pre-market levels. Next catalyst is the investor day on September 15, where management will detail AI roadmap through 2027.

Pre-Market Mover #4: Why Is Eli Lilly ($LLY) Stock Down 3.9% Before the Bell?

Eli Lilly is down 3.9% in pre-market, trading at $934.22 from Monday's $972.10 close on 2.1M shares (versus 1.2M average). A Morgan Stanley analyst downgraded LLY to Equal-Weight from Overweight, citing valuation concerns ahead of Q3 earnings on August 29. The analyst noted LLY is trading at 48x forward earnings — a 35% premium to the pharma peer average — despite slowing GLP-1 adoption growth expectations in Q3.

The stock has run 42% year-to-date, and the downgrade signals profit-taking ahead of earnings. Support is at the 200-day moving average of $912.30. Consensus remains bullish: 35 Buy, 8 Hold, 2 Sell, with an average target of $1,085 — but that assumes Q3 beats estimates. The real test comes Thursday when earnings hit.

For Eli Lilly Q3 earnings details and timing, check the earnings calendar.

Pre-Market Mover #5: Why Is Broadcom ($AVGO) Stock Up 2.8% Before the Bell?

Broadcom is modestly higher at $218.44, up 2.8% from Monday's $212.27 close on 3.4M pre-market shares (versus 1.5M average). The move is tied to positive commentary from Barclays on semiconductor cycle strength. Barclays reiterated an Overweight rating with a $235 target, citing Broadcom's outsized exposure to AI networking — a tailwind expected to drive revenue growth through 2027.

AVGO is trading 1.2% above its 50-day moving average of $216.10. The stock remains 8.2% below its 52-week high of $237.50 from July 15. Consensus: 28 Buy, 4 Hold, 0 Sell, with an average target of $236.80 — representing 8.4% upside. Next earnings are September 12.

What to Expect When Regular Trading Opens at 9:30 AM

Pre-market volume spikes are real but don't guarantee follow-through at the open. Here's what to watch:

Volume fades are common. Pre-market volume for the top 5 movers today is 32.9M shares combined, versus a typical first 30 minutes of regular trading seeing 120-150M. Expect volatility to spike at the open bell and the first 15 minutes to print extreme prices as retail and program trading hit simultaneously.

Gap-and-fade patterns emerge. Stocks that gap up 4-6% in pre-market often fade 1-2% by mid-morning as profit-takers exit overnight winners. Nvidia and AMD are in this zone — watch for resistance at round numbers ($128, $190) in the first hour.

Options markets are already pricing these moves. Call skew on Nvidia has widened 15% overnight, signaling dealers are hedging against further upside. Put activity on Pfizer has exploded — the $26 put is trading at 2.3x typical volume, indicating downside protection buying.

Monitor the Nvidia stock page, Pfizer stock page, and AMD stock page for real-time updates throughout the regular session. For more on reading pre-market movers, see our guide on understanding volume.

Key Technical Levels to Watch at Open

TickerPre-Market PriceResistance (50-Day MA)Support (200-Day MA)52-Week High
NVDA$127.34$124.80$118.20$142.15
PFE$26.44$27.12$24.10$31.80
AMD$189.67$176.20$172.50$192.10
LLY$934.22$912.30$920.10$1,095.20
AVGO$218.44$216.10$201.80$237.50

Frequently Asked Questions

Why do stocks move in pre-market trading if most investors aren't active?

Pre-market moves are driven by overnight earnings reports, late-breaking news (FDA announcements, geopolitical events), and institutional trading desks positioning ahead of the open. Volume is thin — typically 5-15% of regular trading volume — so smaller orders create outsized percentage moves. A 1M share block in pre-market can move a stock 2-3%, while the same block during regular hours creates barely a ripple.

Should I trade on pre-market moves or wait for the 9:30 open?

Pre-market liquidity is poor and spreads are wide (often 3-5 cents on mega-cap stocks versus 1 cent during regular hours). Most professional traders avoid pre-market execution. If you must trade, place limit orders (not market orders) and expect slippage. Most retail brokers don't allow pre-market trading anyway — it's restricted to 4:00-9:30 AM ET for most platforms.

What do I do if a stock gaps down 6% before the open like Pfizer today?

First, identify the catalyst (in this case, an FDA delay). Then check analyst consensus and price targets — if targets are still higher than the new pre-market price, some analysts see it as a buying opportunity. Don't chase it at the open. Wait for the first 30 minutes to settle and look for support at the 50-day or 200-day moving average. For Pfizer, that's $27.12 (50-day) or $26.12 (200-day) — a better entry than chasing at $26.44 pre-market.

How do I know if pre-market moves will stick at the open?

Watch volume. If pre-market volume on a stock is 5-7x normal (like Nvidia at 12.4M versus 2.1M typical), the move is backed by real participation and likely to follow through. If volume is only 1.5-2x normal, it's weak hands and likely fades. check if the move aligns with sector momentum — NVDA's 4.2% gain fits the tech rally, so it's more likely to stick.

When is the next major market event after today?

The FOMC interest rate decision is September 18, 2026 at 2:00 PM ET. That's the next macro catalyst that could impact all five of these names. Before then, individual earnings (Eli Lilly on August 29, Broadcom on September 12) are the key events to track.

What Happens Next

Track the open closely. Nvidia and AMD are likely to follow through higher if the opening auction prints cleanly above pre-market levels. Pfizer and Eli Lilly are vulnerability plays — if the broader market sells off in the first hour, those two will get hit harder given their negative catalysts.

The real test is whether these pre-market gaps survive the first 90 minutes of regular trading. History shows 60% of gaps on catalysts this size persist through the first hour, but 30% fade by lunch. The remaining 10% reverse entirely.

Mark your calendar for Eli Lilly earnings on Thursday, August 29 — if guidance is weak, the downgrade will look prescient and drag the entire healthcare sector lower. Conversely, if LLY beats and raises, the Morgan Stanley downgrade becomes the trade setup of the day.